NCT06832995View on ClinicalTrials.gov

Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Arthropathy of HipArthropathy of Knee
Interventions
DRUG

IV morphine administered during the PACU stay

IV morphine administered during the PACU stay

Trial Locations (1)

35051

Hôpital Privé Sévigné, Cesson-Sévigné

All Listed Sponsors
lead

Hôpital Privé Sévigné

OTHER

NCT06832995 - Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties | Biotech Hunter | Biotech Hunter